Curis Inc.

Curis, Inc. is a US‑based biotech focused on oncology therapeutics. Its pipeline includes Phase I/II drugs Emavusertib, Fimepinostat, CA‑170, CA‑327, and the Roche‑Genentech‑backed Erivedge for basal cell carcinoma.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Professional Services
Industry: Biotechnology Research

Employees: 34
HQ: Lexington

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
CRIS	Curis Inc. Cap: 0.0B	EQUITY	NGM	USD	US2312692005	Active	📈